Several investigations showed that STZ enters the pancreatic β-cells by glucose protein-2 transporter and disrupts the balance between antioxidant and oxidant systems damaging the insulin-producing islet β-cells and inducing the progression of diabetes [23, 24]. This evidence concerns the gene INS and diabetes mellitus.